Bioresorbable Polymers Market Dynamics
Bioresorbable polymers find applications in the medical field, as they are completely biodegradable inside the human body, which in turn avoid the need for second surgery and reduces post-surgery risks. Drug delivery is one of the most commonly used applications of bioresorbable polymers. Poly (D, L-lactic-co-glycolic acid) (PLGA) is the most frequently used bioresorbable polymer for the controlled release of drugs. Various pharmaceutical ingredients such as anti-cancer drugs and antibiotics can be delivered with controlled and constant release by using timely biodegradation of the drug carrier. PLGA is majorly studied for localized drug delivery for treating cancer, glaucoma, and periodontal diseases, and to coat biodegradable and metallic stents. For instance, drug-eluting stents (DES) have shown significant advantages in comparison to their bare metal stent predecessors in reducing the risk of a recurring blockage (restenosis). Bioresorbable polymers market is expected to gain significant traction during forecast period due to high usage in surgery and pharmaceutics such as artificial skin, biodegradable sutures, and implantable carriers for drug delivery. Over the recent past, PLAs are significantly researched upon due to their biodegradability and biocompatibility, leading to applications in medical science. Moreover, ongoing research on 3D printing, is expected to boost growth of the bioresorbable polymers market.
Increasing government efforts to upgrade health sector is driving growth of the bioresorbable polymers market. For instance, government awareness regarding more sustainable products have gained significant traction in the past decade and are guiding future research on the next generation processes and materials. Various funding agencies such as the Bill and Melinda Gates Foundation fund support both, industrial and academic research to overcome product development challenges in manufacturing, frequency of administration, supply chain, and pricing limitations. Recent research on new and improved products is focused on more sophisticated biomedical applications to provide higher efficacy and minimize pain. For instance, in April 2018, Evonik, a global leader for advanced biomaterials and application technology solutions for bioresorbable implants, launched its first product from a new line of RESOMER composite polymers. With the launch of RESOMER, the company will support medical device customers to enhance the performance of orthopedic applications used to grow or heal bones by integrating the osteoconductive properties of calcium-phosphate-based additives into RESOMER.
Market Trends
Bioresorbable Polymers Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients